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Abstract
We have studied an inbred family in
which two cousins presented with the same
clinical features of ataxia telangiectasia
(AT). Both patients are still ambulatory
at ages 25 and 20. Cellular features of
both patients are typical of AT and in-
clude increased radiosensitivity and an
increased level of spontaneously occur-
ring chromosome aberrations in peripheral
blood lymphocytes. Linkage studies and
haplotype analysis show no clear evid-
ence that the gene for AT in this family is
on chromosome Ilq22-23. As previously
reported AT families from complemen-
tation groups AB, C, and D have all
shown linkage to this region of l1q22-23.
Our study is of importance in suggesting
additional locus heterogeneity.
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Ataxia telangiectasia (AT) is a recessively
inherited disorder showing progressive cere-
bellar degeneration in which patients are
predisposed to developing lymphoid tu-
mours."' A gene for ataxia telangiactasia has
been mapped to chromosome llq22-23,15 a
region associated with neurological and im-
mune function loci. In view of reports of at
least four complementation groups, AB, C, D,
and E,5a there may be a number of genes in this
chromosome segment. It is clear, however,
that the AT locus for patients in groups AB,
and C is at 1 1 q22-2336 and both may be
between NCAM/DRD2 and STMY/D11 S385.7
Fibroblasts from a group D patient have been
complemented by chromosome 11 microcell
fusion89 and the group D gene may be distal to
THY-I between D11S147 and D11S133.7'0
One group E family we have studied did not
provide any support for the existence of this
AT locus outside the 1 1q22-23 region.5
In addition to the evidence for genetic heter-
ogeneity as shown by complementation, there
is also evidence for cellular heterogeneity in
AT. About 10 to 15% of subjects show a much
smaller increase in radiosensitivity compared
with other AT patients as measured chromo-
somally and by colony forming assays." 12
The clinical features of AT are progressive
cerebellar ataxia, oculomotor apraxia, an
expressionless face, choreoathetosis, dysarth-
ria, peripheral neuropathy, and ocular telan-
giectasia.' Clinical heterogeneity may be
observed. The progressive cerebellar de-
generation usually begins in infancy or early
childhood' but the age of onset may vary up to
the age of about 12 years.'3 The rate of pro-
gress of the disorder may be variable and the
presence of bulbar telangiectasia is also vari-
able.
In the present study we describe a large
family with two adult cousins with ataxia
telangiectasia with a slightly milder clinical
course. Genetic linkage analysis has not pro-
vided any evidence that the gene for AT in this
family is located at 1 1q22-23.
Case reports
The proband (1I.7) was a 25 year old woman
and the youngest of eight sibs in a family in
which the parents were first cousins and part of
a large inbred family. She was unsteady from
the age of 3 to 4 years but was still able to run
in later childhood, although her walking was
ataxic. She was short ( >-2 SD for age), had
vertical nystagmus, slow saccadic eye move-
ments, slight choreiform movements of the
arms, intention tremors, absent ankle reflexes,
and flexor plantars. Dysarthria was present,
developing in the teenage years. No cutaneous
or ocular telangiectasia was evident. CT scan
showed enlargement of the fourth ventricle
and widening of all cerebellar fissures. AFP
and immunoglobulin levels were normal.
There was no intellectual impairment.
Her male cousin (II.8) presented at the age
of 3 to 4 years with an ataxic gait and constant
drooling. At the age of 20 he had progressive
unsteadiness in walking, dysarthria, drooling,
vertical nystgamus and loss of pursuit move-
ments, choreiform movement of the hands,
moderate peripheral ataxia, dysdiadochokine-
sis, absent ankle reflexes, flexor plantars, de-
creased sensitivity to vibration and pinprick,
and pes cavus. A CT scan showed atrophy of
the posterior fossa structures. There was no
cutaneous telangiectasia. AFP and immuno-
globulin levels were normal.
The remainder of the sibs and the four
parents were examined and were normal (fig
1). One cousin of I.2 has Wilson's disease.
Materials and methods
CELLS AND CULTURE CONDITIONS
A normal skin fibroblast strain Con Bu,
together with the classical AT fibroblast strain
AT3BI and cells from the two patients II.7
and 11.8, were grown in Dulbecco's modified
Eagles medium (DME) supplemented with
10% FCS (Flow Laboratories), glutamine,
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Figure 1 Pedigree of a family showing two cousins with ataxia telangiectasia. Haplotypes are given for all family
members across a region of chromosome 11q22-23 between tyrosinase and ETS.
penicillin (100 IU/ml), and streptomycin
(100 ptg/ml) and incubated at 37°C in 5% CO2
in air.
COLONY FORMING ASSAYS
Different cell dilutions irradiated with doses of
y rays between 1 00 and 5 00 Gray were seeded
on to lethally irradiated feeder layers of the
same cells (6 x 104 per 9 cm dish irradiated
with 35 Gray -y rays). Cells were left for 14 to
21 days in an incubator to form colonies with a
change of medium once a week and were then
stained with methylene blue and counted.
HUMAN-HAMSTER CELL HYBRIDS
Mononuclear cells separated from whole blood
were fused with hamster a23 cells in 50%
PEG 1000 for approximately one minute. Ad-
herent hybrid colonies were selected in HAT
medium. (Non-adherent lymphocytes were
washed away.)
CHROMOSOME PREPARATIONS
For lymphocyte chromosome preparations
04 ml of heparinised whole blood was cul-
tured in 4-0 ml of RMPI 1640 supplemented
with 10% FCS, streptomycin, and penicillin.
Cultures were fixed at 72 hours. Lymphocytes
were also irradiated four hours before harvest
at 72 hours (in the G2 phase of the cell cycle). A
Pantak constant potential industrial radio-
graphy unit at 245 kev/ 12 mA and half value
thickness copper filter of 1 mm was used. The
filter object distance was 30 cm and the dose
rate 1 01 Gray/minute.
For trypsin banded chromosomes, slide pre-
parations were incubated for one hour at 95'C,
immersed in Hanks Balanced salt solution
(1:1 x 10 HBSS/x 1 HBSS) for 10 minutes,
washed in pH 6 8 buffer, immersed in 2 8%
trypsin in buffer for about 50 seconds, and
rinsed in saline. Metaphases were stained with
20% Leishman's stain in pH 6 8 buffer for
about four minutes.
DNA MARKERS
The 11 q22-23 markers used are given in table
1. Inserts were isolated from vector sequences
by gel purification in all cases. When inserts
contained repeated sequences, only a part of
the insert corresponding to single copy se-
quence was used.
DNA PREPARATIONS AND ANALYSIS
DNA used for analysis of polymorphisms was
extracted from blood samples according to the
method of Kunkel et a114 and digested with
restriction enzymes using the manufacturer's
recommended conditions. II.6 and II.7 were
sampled on two separate occasions and reana-
lysed. Southern blotting, probe radiolabelling,
and hybridisation were carried out as pre-
viously described.4 Enzymes used to detect
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Table 1 Restriction fragment length polymorphisms detected by chromosome 1 Iq22.23
probes.
Locus Probe Enzyme Alleles (kb) Frequency
TYR pTyrs-33 TaqI 2-8/2-4 0 52/0-48
D11S84 p2-7-ID6 TaqI 6 4/4-2 0 28/0-72
D11S36 12-14 RsaI 2-95/2-10 0-59/0-41
D11S35 02-22 MspI/TaqI 4 4/4-2 0-49/0-51
STMY STMY cDNA TaqI 4-6/21 + 1-0 0 54/0 46
DIIS385 pCJ52-75 MspI 5-5/3 5+2-0 0-89/0-11
DlIS384 cCJ52 193 TaqI 8-5/4 3 0 26/0 74
Dl I S535 pJ12-8 XmnI 3 8/2 8 0-67/0 33
DlI S424 pCJ52-77 Msp 7 3/6-8 0-25/0 75
DlI S132 CRI-L424 EcoRI 9-0/6-7 + 2-3 0-54/0-46
DRD2 XhD2DG1 TaqI 6-6/3-7 + 2-9 0 24/0-76
NCAM pHFM1 BamHI 9-8/6-3 + 3-8 0-77/0-23
DI1S351 pCJ52 208 MspI 4-0/3-2 0-41/0-59
DIIS144 pYNB3 12 MspI 2 8/2-4 0-55/0-45
APOAI ApoAI SstII 4-2/3-2 0-96/0-04
DIIS29 pL7 TaqI 13-9/10-9/9-2 0-23/0-76/0-01
CD3E pDJ4 TaqI 8-7/8-1 0-67/0 33
DIIS382 cCJ52 12 TaqI 28/24 0-18/0-82
THY-I pGSEBg.4 MspI 0-9/0-8 0 28/0 72
ETS pHE5-4 AvaII 2-4/2 2 0-19/0-81
Dl IS528 Microsatellite repeat (see Materials and methods)
The primers used to amplify the microsatel-
lite repeat at the locus Dl S528 were as
follows: primer 42026 5' AATGGTGTCCC-
CACACATGT, primer 42027 5' TCCTAC-
CTACCGAGCTTAAA.'5 Primer 42027 was
end labelled with 30 jiCi 7y32P ATP using 10 U
polynucleotide kinase and purified by centrifu-
gation through a sephadex G25 column. Poly-
merase chain reaction was carried out in a 25 11
volume containing 200 ng of genomic DNA
template, 10 pmol each of the labelled and
unlabelled primers, 200 gmol/l each of dATP,
dCTP, and dTTP, 0 5 U of Taq polymerase
(Boehringer) and Taq polymerase buffer
(Boehringer). Samples were processed
through 36 cycles consisting of 45 seconds at
94°C (three minutes for cycle 1), 30 seconds at
52'C, and 30 seconds at 72°C (five minutes for
cycle 36). Aliquots of the PCR reactions (2 gl)
were mixed with 8 pl formamide sample
buffer, denatured at 94°C for three minutes,
and 3 to 4 gl electrophoresed on a 6% denatur-
ing polyacrylamide sequencing gel. Gels were
fixed, dried, and autoradiographed for 15
hours using X-OMAT AR film (Kodak).
LINKAGE ANALYSIS
The two point and multipoint analyses were
performed using LINKAGE.'6 Published
values for maker allele frequencies (HGM10)
were used in linkage calculations. The AT
gene frequency was set to 0-003 and the gene
assumed to be fully penetrant. A 2:1 ratio of
female:male recombination was used as sug-
gested from previous results.5
DNA FINGERPRINTING
DNA samples from lymphoblastoid cell lines
(5 to 8 gg) were digested overnight with HinfI
(New England Biolabs) and analysed on 0-7%
agarose gels in TBE containing 0-5 jg/ml ethi-
dium bromide. Gels were run at 75 V until a
2 3 kb marker fragment had migrated 20 cm.
Gels were treated with 0 25 mol/l HC1 (15
minutes), 0 5 mol/l NaOH, 1 5 mol/l NaCl (30
minutes), and 05 mol/l Tris HCI pH 75,
3 mol/l NaCl (30 minutes). Blotting on to
Hybond N (Amersham) and UV fixation were
carried out according to manufacturers' in-
structions.
Multilocus probes (MLPs) 33 15 and 33 6'7
were labelled and hybridised to membranes.
Following stripping (30 minutes at 45°C in
0 4mol/l NaOH, followed by 30 minutes at
45'C in 0-2mol/l Tris pH7-5, 0-1% SDS,
0 1 x SSC), membranes were rehybridised
with cocktails of single locus probes (MS8,
MS43A, and pX3 or MS31 and MS1). Single
locus probes were labelled by random hexamer
priming. Prehybridisation was in 0-5 mol/l
Na2HPO4, 7% SDS, 1 mmol/l EDTA, 0 1%
BSA for 20 minutes at 650C, and hybridisation
was in 1 x SSC, 6% PEG 6000 for 15 hours at
65°C. Washing was carried out at 65°C in
40 mmol/l Na2 HPO4 pH 7 2, 0 1% SDS (15
minutes) followed by 0-5 x SSC, 0-01% SDS
(2 x 15 minutes) and 02 x SSC 0-01% SDS
(2 x 15 minutes). Autoradiography was carried
out at - 70'C using Amersham Hyperfilm
MP. 17a
Results
In addition to the clearcut clinical features of
AT we also show that these patients have the
typical cellular features of AT.
PRESENCE OF SPONTANEOUS CHROMOSOME
ABNORMALITIES IN LYMPHOCYTES
One of the characteristic features of AT lym-
phocytes and a useful diagnostic aid is the
presence of translocation chromosomes, es-
pecially involving chromosomes 7 and 14 in
about 10% of circulating T lymphocytes.1820
In the present patients II.7 and II.8, 4/50 and
4/50 cells respectively showed the presence of
translocations or deletions as shown in table 2.
Only one of these translocations, t(7;14)
(q35;ql 1) in patient 11.8, is typical of AT. The
remaining chromosome translocations and de-
letions are more unusual. The telomeric fusion
in patient II.8 is not unusual in AT patients
but they are normally associated with the pres-
ence of large translocation clones of lympho-
cytes.2' No such clonal development was seen
in lymphocytes from these patients. There was
no evidence of a constitutional rearrangement
or deletion at 1 Iq22-23 in patients II.7 and
II.8.
CHROMOSOMAL RADIOSENSITIVITY IN PATIENTS
II.7 AND II.8
After exposure of lymphocytes to both 0 5
Gray and 1 0 Gray x rays in the G2 phase of the
cell cycle, both patients showed the large in-
Table 2 Chromosome rearrangements observed in 50
cells from each of two A T homozygotes.
Patient Rearrangement No of cells
I1.7 46,XX, t(2;6) (p21;pter) 1
46,XX, del(7) (qter--p15:) 1
46,XX, -15, -15, t(l9;?) 1
46,XX, t(7; 14) (p 1 5;q32) 1





group.bmj.com on January 6, 2016 - Published by http://jmg.bmj.com/Downloaded from 
Hernandez, McConville, Stacey, Woods, Brown, Shutt, Rysiecki, Taylor
crease in induced chromatid type damage,
compared with a normal control (table 3),
which is typical of AT patients. No other
family member tested showed the increased
radiosensitivity. In particular lymphocytes
from unaffected sib 11.6 were compared with
those from affected sib II.7 after exposure to 7
rays and shown not to have increased radio-
sensitivity (table 3).
COLONY FORMING ABILITY OF CULTURED SKIN
FIBROBLASTS FROM PATIENTS II.7 AND II.8
AFTER EXPOSURE TO y RAYS
The colony forming ability of fibroblasts from
patients 11.7 and II.8 are shown in fig 2
together with normal fibroblasts and cells from
AT3BI, a classical AT patient from comple-
mentation group AB. Clearly the survival of
cells of II.7 and II.8 is greatly reduced com-
pared with normal and no different from
AT3BI.
LOCALISATION OF THE AT GENE IN THIS FAMILY
We typed each family member for 21 markers
(table 1) at 11 q22-23 and haplotypes together
with the family pedigree are given in fig 1. The
results were used to compute pairwise lod
scores between each marker and AT and were
also used in a multipoint analysis. Markers
DiiS385, DiiS535, D11S424, CD3, and
THY-I were uninformative. Significant nega-
tive lod scores (< - 2) were obtained for
markers D 1S84, STMY/DJ1 S85, NCAM/
DRD2, DIIS351/DIIS144, and ETSJ. The
highest pairwise lod scores were obtained with
DlIS35 (Z= 041 at 0=0), DlIS36 (Z= 0-26
at 0=0), and DiiS132 (Z=0 26 at 0=0).
Location scores (fig 3) showed significant
negative values when AT was placed at 0= 0
from Dl S351i/D 1 S144, NCAM/DRD2, and
STMY/DI I S385. For the intervals in
between scores were mostly negative, only
exceeding zero when close to THY-I. The
reason for this could be the uninformativity of
this marker and the large interval between
ETSI and THY-I. Using the more distal
marker D 1S528, which has been mapped
between ETS and THY-I, we could show that
II.6 and II.7 had identical alleles, which were
Table 3 Induced chromosome damage following exposure at G2 to ionising radiation.
No of
Patient cells r dic f ctg ctb csg tri qr
After exposure to 0-5 Gray x rays
ATII.7 50 0 0 9 64 14 0 2 4
ATII.8 50 0 1 4 44 19 0 0 0
Normal 50 0 0 0 8 0 0 0 0
After exposure to 1 0 Gray x rays
AT11.7 (i) 50 0 0 9 107 52 0 7 2
(ii) 50 0 0 8 110 38 0 5 1
ATII.8 50 0 2 5 88 29 0 7 2
II.1 50 0 0 1 8 0 0 0 0
II.3 50 0 0 0 9 0 0 0 0
11.4 50 0 0 0 7 2 0 0 0
AT 3BI 50 1 2 7 58 40 0 2 4
Normal 50 0 0 1 8 0 0 0 0
After exposure to 1 0 Gray y rays
ATII.6 20 0 0 0 16 5 0 0 0
ATII.7 20 0 0 3 46 32 0 3 1
r = rings, dic = dicentrics, f= fragment, ctg = chromatid gaps, ctb = chromatid breaks,
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Figure 2 Survival of skin fibroblasts from the two
cousins I.7 (filled circles) and II.8 (diamonds) after
exposure to - rays. Survival of cells from group A A T
patient A T3BI (filled squares) and a control (open
circles) are also shown.
different from II.8. This suggests there is
indeed no linkage of AT with THY-I or the
more distal marker DI I S528 in this family.
If the AT gene were on this region of
chromosome 11 in this family we would expect
(1) that patient 11.7 would have a unique
haplotype around the AT gene compared with
her unaffected sibs, and (2) I.2 and I.3 would
share a common region of chromosome 11 near
the AT gene and this same chromosome would
be present in the two patients. Inspection of
the haplotypes showed the reasons for the
negative lod scores obtained, in that patient
II.7 and her unaffected sib II.6 have identical
haplotypes. The two affected cousins, II.7 and
II.8, also show very little haplotype similarity.
Haplotype C shown by I.2 and I.3 has only
been inherited by 11.8 and not by II.7. Neither
of the predictions were therefore observed.
Since all possible haplotype combinations are
represented (in the larger side of the family) in
normal sibs the AT gene is unlikely to be in
phase with either C or D maternal haplotypes.
There is no evidence to support the hypothesis
that the AT gene is located in this region of
chromosome 11 in this family.
Other explanations for these observations
have been considered, but are regarded as
unlikely. (1) The possibility of a mix up in the
bloods was eliminated by repeating the typings
of II.6 and I.7 on DNA from a second blood
sample. The duplicate samples confirmed that
both sibs have identical haplotypes. In addi-
tion, DNA from sibs 11.6 and II.7 were shown
to be quite distinct since the sibs could be
shown to have inherited different alleles for
non-chromosome 1 1 markers. The maternally
derived haplotype was checked by isolating the
maternal chromosome D from II.4 in a
human/hamster hybrid cell line and the typing
repeated. This yielded the same alleles as the
derived haplotype. (2) The possibility of non-
paternity was also considered. The use of
various multilocus probes, biallelic probes,
and hypervariable probes suggested that this
was unlikely. Multilocus probes were used to
calculate percentage band share. The expected
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Figure 3 Location scores for a seventeen point map. (DI1IS528, DI11S384, Dl11S36,
and tyrosinase were not included because of lack of information on their precise
location.)
value for first degree relatives on average is
62.5%, II.6 and II.7 shared 64 0% of their
bands, which is consistent with a first degree
relationship such as full sibs. The single locus
analysis showed the presence of 17 bands
within the sibship from the five probes used. If
all the sibs share the same parents we would
expect a maximum of 20 bands. The presence
of more than 20 bands would indicate that one
or more of the sibship had a different parent
from the rest. Overall, these results support
the hypothesis that II.6 and II.7 are full sibs.
We cannot absolutely rule out non-paternity
but clearly this is very unlikely. A major dis-
parity, however, between the affected cousins
is that II.7 does not show haplotype C, which
is a maternal chromosome. (3) There is a
possibility that there is a submicroscopic dele-
tion in one of the chromosomes of II.7 which
would make her hemizygous for the AT allele,
while her normal sib, 11.6, has a normal allele,
giving her a normal phenotype. An alternative
might be that a rare double recombination
might have occurred between the maternal
chromosomes, whereby II.7 inherited part of
chromosome C with the mutant allele. Both a
double recombination and deletion would
explain the apparent haplotype identity
between II.6 and II.7 and lack of similarity
between II.7 and II.8. The combination of B/
C is, however, already observed in sib I.1 for
the region above NCAM/DRD2 with no phe-
notypic effect. The combination B/C below
NCAMjDRD2 is, however, not seen in any of
the normal sibs, and so a rare genetic event
such as a double recombination or gene con-
version might have occurred in this region.
It is striking, however, that two observations
consistent with the AT gene being on chromo-
some 11 in this inbred family are (1) that both
of the sibs I.2 and I.3 with AT children share
the same chromosome (C in I.2), and (2) that
patient II.8 is homozygous for all 16 markers
between tyrosinase and CD3 inclusively. On
the smaller side of the family, the haplotypes
are consistent with the gene being on chromo-
some 11.
Discussion
The two AT patients described here are clinic-
ally unusual in still being ambulatory at the
ages of 25 and 20 respectively, even though
ataxic gait was first noted between the ages of 3
and 4 in both. Neither patient had evidence of
cutaneous or bulbar telangiectasia, but all the
remaining clinical features of AT were pre-
sent: progressive cerebellar ataxia, dysarthria,
flexor plantar responses, choreoathetoid move-
ments, odd eye movements, an expressionless
face, drooling (in II.8), and short stature (in
I.7). AFP levels were normal in both patients.
Qualitatively some of the spontaneous chro-
mosome aberrations in both patients were dif-
ferent from other patients, but increased
radiosensitivity was typical of AT patients.
Both the cellular features and clinical features
were therefore still typical of ataxia telangiec-
tasia.
In this inbred family it was expected that
both affected subjects would show similar hap-
lotypes and a high degree of homozygosity.
Ninety percent homozygosity was observed in
patient II.8 but not in II.7. Patient II.8 inher-
ited chromosome C, which both parents of the
AT children also shared but was not present in
II.7. In the larger side of the family, II.7
showed the same haplotype as a phenotypically
normal sib, II.6. In 50 families haplotyped this
is the only instance we have encountered where
an apparently identical haplotype in unaffected
and affected subjects cannot easily be explained
on the basis of a single recombination event5
(unpublished results). The proband II.7 has
not inherited the maternal chromosome C
which in her cousin appears to contribute to
AT, but instead has a different haplotype. One
explanation of this is that she is homozygous
for a gene at a different locus, and therefore the
extended family may be carrying more than
one mutation for AT. If separate loci were
responsible for the AT seen in this family then
phenotypic differences might be expected
between the cousins. Minor differences, for
example, height and drooling, exist, but the
similarities appear stronger, and this especially
applies to the cellular radiosensitivity.
The possibility of a rare double recombina-
tion between the maternal chromosomes
would theoretically explain the haplotype
similarity between II.6 and II.7 and the dif-
ference from II.8. The recombination would
have to occur telomeric to NCAM/DRD2
because the combination B/C in this region is
the only haplotype not presented in an unaf-
fected subject. This is of interest because hap-
lotype analysis of other reported families
probably places AT group AB and group C
centromeric to NCAM/DRD2.57 Some evid-
ence suggests that the locus for complemen-
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tation group D patients may be in the more
telomeric region'0 between markers DIIS147
and DII S133, which are distal to THY-1.7 We
do not know if our patients II.7 or II.8 belong
to complementation group D but our evidence
suggests that the AT gene in this family is not
linked to THY-I or DJJS528 distal to it.
The AT homozygotes in this family appear
to show a slower or less severe cerebellar
degeneration compared with many other
patients as judged by their degree of mobility
at their age. In the family described here
clinical features are milder than usual but with
the presence of a typically high level of radio-
sensitivity. Other patients appear to have
smaller increases in radiosensitivity as
measured chromosomally or by cell survival,
but as severe or possibly more severe cerebel-
lar ataxia than seen here in patients II.7 and
II.8. There does not appear to be a quantita-
tive relationship between the degree of cere-
bellar ataxia and the level of radiosensitivity in
AT patients. It is possible therefore that other
genes may in some circumstances selectively
modify either the radiation response or the
cerebellar degeneration in different AT
patients. A similar degree of radiosensitivity is
seen in patients with Nijmegen breakage syn-
drome (NBS), but in the absence of any cere-
bellar ataxia.22 Cells from NBS patients,
however, complement AT patients' cells
suggesting the presence of a different gene
producing increased radiosensitivity.22 There
may therefore be several genes producing a
phenotype with increased radiosensitivity with
or without ataxia.
At present the simplest way in which to
interpret the observations presented here is
that in this family the gene for AT is not on
chromosome 1 Iq22-23.
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